Cellular effects of cancer chemotherapy administration

Journal of Intravenous Nursing

Volumn 23, Issue 1, 2000, Pages 44-51

  Moran, Peggy ^a  

^a South Shore Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; ASPARAGINASE; BLEOMYCIN; BUSULFAN; CARBOPLATIN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE DERIVATIVE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; FLUOROURACIL; HORMONE; HYDROXYUREA; IFOSFAMIDE; LOMUSTINE; MELPHALAN; METHOTREXATE; NITROSOUREA DERIVATIVE; PACLITAXEL; PREDNISONE; SEMUSTINE; TIOGUANINE; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; VINDESINE;

ALOPECIA; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CARDIOTOXICITY; CELL CYCLE; DRUG CYTOTOXICITY; HUMAN; LIVER TOXICITY; NAUSEA; PATIENT MONITORING;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DIVISION; HUMANS; NEOPLASMS; ONCOLOGIC NURSING;

EID: 0033972338     PISSN: 08965846     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Dorr RT, Fritz WL. Cancer chemotherapy handbook. New York: FL Sevier Science Publishing Company, Inc., 1980.
2. Ingwersen KC. Cell cycle kinetics and antineoplastic agents. In: Barton-Burke M, Wilkes G, Ingwersen, KC, et al, eds. Cancer Chemotherapy: A Nursing Process Approach, 2nd ed. Sudbury, MA: Jones and Bartlett Publishers, 1996:21-42.
3. Bender B. Implications of antineoplastic therapy for nursing. In: Clark JC, McGee RF, eds. Oncology Nursing Society: Core Curriculum for Oncology Nursing, 2nd ed. Philadelphia: WB Saunders Co., 1992:641-656.
4. DeVita VT Jr. Principles of chemotherapy. In Devita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology, 4th ed. Philadelphia: JB Lippincott Co., 1993:333-348.
5. Skipper HE. Combination therapy: some concepts and results. Cancer Chemotherapy Report 1974;4 (part 2):137.
6. Goodman MS. Cancer chemotherapy and care, 3rd ed. Princeton, NJ: Bristol-Myers Squibb Company, 1992.
7. Weiss GR. Clinical oncology. Norwalk, CT: Appleton & Lange, 1993.
8. Tripp BR. Chemotherapy. In: Multimodal Therapy in Oncology Nursing. St. Louis: Mosby-Year Book, Inc., 1996.
9. Haskell LM. Principles of cancer chemotherapy. In: Cancer treatment, 4th ed. Haskell LM, ed. Philadelphia: WB Saunders Co., 1995.
10. Hubbard SM. Chemotherapy and the nurse. In Marino LB, ed. Cancer nursing. St. Louis: Mosby Publishing, 1981:20-44.
11. Groenwald SL, Frogge MH, Goodman M, et al, eds. Chemotherapy: toxicity management. In: Groenwald SL, Frogge MH, Goodman M, et al, eds. Comprehensive Cancer Nursing Review, 4th ed. Sudbury, MA: Jones and Bartlett Publishers, 1998:151-160.
12. Wujcik D. Biotherapy. In Liebman MC, Camp-Sorrell D, eds. Multimodal Therapy in Oncology Nursing. St. Louis: Mosby-Year Book, Inc., 1996:74-88.
13. Mahood DJ, Dose AM, Loprinzi CL, et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 1991;9: 449-52.
14. Neupogen insert. Amgen, Inc. 1998.
15. Beck SL. Prevention and management of oral complications in the cancer patient. Current Issues in Cancer Nurs Prac 1992;1(6):1-12.